# DarioHealth Corp.: filings

DRIO · Nasdaq · CIK 1533998 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/drio.md) · [Financials](/companies/drio/financials.md) · [Filings](/companies/drio/filings.md) · [Insiders](/companies/drio/insiders.md)

## Reports and events: 242 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 339, 8-K 145, 10-Q 41, 3 38, CORRESP 38, EFFECT 29, UPLOAD 29, D 23, S-3 20, SC 13G/A 19, S-8 18, DEF 14A 16, SC 13G 14, SCHEDULE 13G/A 14, 10-K 13, 424B3 12, PRE 14A 11, SD 11, 4/A 9, 424B5 8, S-1 7, S-3/A 7, S-1/A 6, 8-K/A 4, POS AM 4, SC 13D 4, SCHEDULE 13G 4, 10-Q/A 3, SC 13D/A 3, 424B7 2, 25-NSE 1, 3/A 1, 424B4 1, 8-A12B 1, ARS 1, CERTNAS 1, CT ORDER 1, D/A 1, DEL AM 1, DRS 1, PRER14A 1, SP 15D2 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-04 | 16:05 ET | [8-K](/filings/0001104659-26-105495.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-105495 |
| 2026-08-21 | 16:05 ET | [8-K](/filings/0001104659-26-099678.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-099678 |
| 2026-08-11 | 06:05 ET | [10-Q](/filings/0001104659-26-093645.md) | Quarterly report, period 2026-06-30 | 0001104659-26-093645 |
| 2026-07-22 | 17:19 ET | [8-K](/filings/0001104659-26-085900.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-085900 |
| 2026-07-10 | 17:10 ET | [8-K](/filings/0001104659-26-082715.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-082715 |
| 2026-05-13 | 06:05 ET | [10-Q](/filings/0001104659-26-059676.md) | Quarterly report, period 2026-03-31 | 0001104659-26-059676 |
| 2026-04-13 | 08:21 ET | [8-K](/filings/0001104659-26-042362.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-042362 |
| 2026-03-30 | 17:31 ET | [8-K](/filings/0001104659-26-036834.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-036834 |
| 2026-03-19 | 06:05 ET | [10-K](/filings/0001104659-26-031621.md) | Annual report, period 2025-12-31 | 0001104659-26-031621 |
| 2026-02-02 | 16:32 ET | [8-K](/filings/0001104659-26-009247.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-26-009247 |
| 2026-01-29 | 16:06 ET | [8-K](/filings/0001104659-26-007974.md) | 5.07 Shareholder vote results | 0001104659-26-007974 |
| 2025-12-22 | 16:12 ET | [DEF 14A](/filings/0001104659-25-123724.md) | Proxy statement, period 2026-01-29 | 0001104659-25-123724 |
| 2025-11-13 | 06:05 ET | [10-Q](/filings/0001104659-25-110730.md) | Quarterly report, period 2025-09-30 | 0001104659-25-110730 |
| 2025-11-10 | 16:17 ET | [8-K](/filings/0001104659-25-109166.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-25-109166 |
| 2025-09-25 | 17:18 ET | [8-K](/filings/0001104659-25-093431.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-093431 |
| 2025-09-19 | 17:01 ET | [8-K](/filings/0001104659-25-091718.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-25-091718 |
| 2025-09-12 | 17:24 ET | [8-K](/filings/0001104659-25-089629.md) | 8.01 Other events | 0001104659-25-089629 |
| 2025-08-25 | 16:05 ET | [8-K](/filings/0001104659-25-082513.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-082513 |
| 2025-08-12 | 06:06 ET | [10-Q](/filings/0001558370-25-011130.md) | Quarterly report, period 2025-06-30 | 0001558370-25-011130 |
| 2025-07-23 | 17:08 ET | [8-K](/filings/0001104659-25-070069.md) | 5.07 Shareholder vote results | 0001104659-25-070069 |
| 2025-07-10 | 16:05 ET | [8-K](/filings/0001104659-25-066982.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-066982 |
| 2025-05-30 | 17:16 ET | [DEF 14A](/filings/0001104659-25-054861.md) | Proxy statement, period 2025-07-23 | 0001104659-25-054861 |
| 2025-05-29 | 16:05 ET | [8-K](/filings/0001104659-25-054236.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-25-054236 |
| 2025-05-21 | 07:05 ET | [8-K](/filings/0001104659-25-051292.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-25-051292 |
| 2025-05-14 | 06:06 ET | [10-Q](/filings/0001558370-25-007640.md) | Quarterly report, period 2025-03-31 | 0001558370-25-007640 |
| 2025-05-06 | 07:30 ET | [8-K](/filings/0001104659-25-044809.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-25-044809 |
| 2025-04-28 | 16:05 ET | [8-K](/filings/0001104659-25-040182.md) | 5.07 Shareholder vote results | 0001104659-25-040182 |
| 2025-04-21 | 17:10 ET | [8-K](/filings/0001104659-25-036910.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-036910 |
| 2025-03-19 | 16:05 ET | [8-K](/filings/0001104659-25-025549.md) | 3.01 Delisting notice | 0001104659-25-025549 |
| 2025-03-14 | 19:57 ET | [8-K](/filings/0001104659-25-023589.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-023589 |
| 2025-03-10 | 16:05 ET | [DEF 14A](/filings/0001104659-25-022150.md) | Proxy statement, period 2025-04-28 | 0001104659-25-022150 |
| 2025-03-10 | 06:06 ET | [10-K](/filings/0001558370-25-002527.md) | Annual report, period 2024-12-31 | 0001558370-25-002527 |
| 2025-02-27 | 16:15 ET | [8-K](/filings/0001104659-25-018230.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-018230 |
| 2025-01-22 | 16:04 ET | [8-K](/filings/0001104659-25-005237.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-005237 |
| 2025-01-10 | 16:30 ET | [8-K](/filings/0001104659-25-002576.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-25-002576 |
| 2024-12-18 | 16:30 ET | [8-K](/filings/0001104659-24-129777.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-129777 |
| 2024-12-18 | 16:05 ET | [8-K](/filings/0001104659-24-129752.md) | 5.07 Shareholder vote results | 0001104659-24-129752 |
| 2024-11-07 | 06:05 ET | [10-Q](/filings/0001558370-24-014735.md) | Quarterly report, period 2024-09-30 | 0001558370-24-014735 |
| 2024-10-24 | 16:15 ET | [DEF 14A](/filings/0001104659-24-111163.md) | Proxy statement, period 2024-12-18 | 0001104659-24-111163 |
| 2024-09-20 | 16:05 ET | [8-K](/filings/0001104659-24-101690.md) | 3.01 Delisting notice | 0001104659-24-101690 |
| 2024-09-13 | 16:05 ET | [8-K](/filings/0001104659-24-099762.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-24-099762 |
| 2024-08-08 | 06:05 ET | [10-Q](/filings/0001558370-24-011453.md) | Quarterly report, period 2024-06-30 | 0001558370-24-011453 |
| 2024-06-28 | 16:31 ET | [8-K](/filings/0001104659-24-076313.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-24-076313 |
| 2024-06-25 | 16:05 ET | [8-K](/filings/0001104659-24-074740.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-24-074740 |
| 2024-06-05 | 08:30 ET | [8-K](/filings/0001104659-24-068526.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-068526 |
| 2024-05-15 | 06:06 ET | [10-Q](/filings/0001544784-24-000067.md) | Quarterly report, period 2024-03-31 | 0001544784-24-000067 |
| 2024-05-01 | 17:24 ET | [DEF 14A](/filings/0001104659-24-055848.md) | Proxy statement, period 2024-06-25 | 0001104659-24-055848 |
| 2024-04-22 | 16:50 ET | [8-K](/filings/0001104659-24-050049.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001104659-24-050049 |
| 2024-04-19 | 16:11 ET | [8-K](/filings/0001104659-24-049443.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-24-049443 |
| 2024-04-05 | 16:30 ET | [8-K](/filings/0001104659-24-044299.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-044299 |

Page 1 of 5. [Older](/companies/drio/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:13 ET. No prices; not investment advice.